Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes
FIMDM_CVD
2 other identifiers
interventional
98
1 country
1
Brief Summary
The investigators propose an evaluation that will assess three important components of risk communication:
- 1.provide patients with personalized risk communication using the risk calculator developed by FIMDM and health information taken from the Living with Coronary Artery Disease program
- 2.provide personalized tailored patient feedback to help initiate and maintain specific cardiovascular CVD-related behaviors(e.g., medication adherence, exercise, diet, smoking cessation) to reduce their risks.
- 3.evaluate how this feedback can be incorporated into clinical care by examining 3 month patient outcome and provider responses to the risk information.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2010
CompletedFirst Posted
Study publicly available on registry
June 2, 2010
CompletedStudy Start
First participant enrolled
December 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedJuly 22, 2014
July 1, 2014
11 months
May 28, 2010
July 18, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cardiovascular Disease (CVD) Risk Knowledge Assessment
Trained personnel will obtain the patients' outcome values (i.e., weight, height, BP) at baseline and subsequent 3-month outcome using a digital sphygmomanometer and digital scale according to a standard protocol. The baseline interview includes demographics and an assessment of patients' health behavior, perceived risk, and interactions with their provider. At 3-month follow-up visit, patients will also undergo an in-person interview to determine changes in weight, smoking status, medication adherence, decisional conflict, knowledge.
Baseline and 3 month @ study end
Study Arms (2)
Control
NO INTERVENTIONReceive primary care and management of CVD according to the discretion of their primary care provider. They will also receive generic educational information concerning CVD at baseline and at study end (at their request). We will collect outcomes at baseline and 3-months.
Web-based Intervention
EXPERIMENTALGiven current risk assessment for CVD based on Health Dialog Cardiac Risk Calculator, recommendations for behavior change, and Health Dialog's Living with Coronary Heart Disease. Can change initial patient risk information provided by the Risk Calculator during the initial visit, noting what they are will work on during the study. Sent monthly email reminders to log onto the system to choose that months' behavioral modules. Given a choice of at least 2 health behavior modules per month (smoking cessation, exercise, diet, and weight) to improve their CVD risk. Information on risk, CVD knowledge, medication management and side effects will be provided to all participants. It will also provide tailored information to help the individual initiate and maintain these behaviors.
Interventions
1. Health Dialog Cardiac Risk Calculator 2. Health Dialog's Living with Coronary Heart Disease 3. Tailored intervention including health behavior modules such as smoking cessation, exercise, diet, and weight
Eligibility Criteria
You may qualify if:
- cardiovascular disease (CVD)
- CVD risk equivalent (peripheral arterial disease, history of ischemic stroke, or diabetes)
You may not qualify if:
- metastatic cancer,
- dementia,
- active psychosis
- end-stage renal disease
- no access to computer with Internet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Health System
Durham, North Carolina, 27705, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hayden Bosworth, PhD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2010
First Posted
June 2, 2010
Study Start
December 1, 2010
Primary Completion
November 1, 2011
Study Completion
February 1, 2014
Last Updated
July 22, 2014
Record last verified: 2014-07